11 – 20 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
- Contribution to journal › Article
- 2021
-
Mark
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance
- Contribution to journal › Article
-
Mark
Comorbidities in multiple myeloma and implications on survival : A population-based study
- Contribution to journal › Article
-
Mark
Burden of Treatment-Induced Peripheral Neuropathy in Patients with Multiple Myeloma in Sweden
- Contribution to journal › Article
-
Mark
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
- Contribution to journal › Article
-
Mark
Untangling fracture risk in monoclonal gammopathy of undetermined significance : A population-based cohort study
- Contribution to journal › Article
-
Mark
A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female
- Contribution to journal › Article
- 2020
-
Mark
Outcome and characteristics of non-measurable myeloma : A cohort study with population-based data from the Swedish Myeloma Registry
- Contribution to journal › Article
-
Mark
Second malignancies in multiple myeloma; emerging patterns and future directions
- Contribution to journal › Scientific review
- 2019
-
Mark
Aspects of Phagocyte Function in Multiple Myeloma
- Thesis › Doctoral thesis (compilation)
